Cancer Biology & Therapy, Volume 19, Issue 11 (2018)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Cancer Biology & Therapy, Volume 19, Issue 11 (2018)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Volume 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2011 Vol 10, 2010 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Letter to the Editor

Letter
A rare case of multicentric castleman's disease transforms into multiple myeloma and its successful treatment
Dan Yang, Xuan Zhou, Youcai Zhao, Shibin Cao, Ailing Su, Xuezhong Zhang, Yanli Xu & Xiuqun Zhang
Pages: 949-952
Published online: 30 Apr 2018
AbstractforA rare case of multicentric castleman's disease transforms into multiple myeloma and its successful treatment | Full Text | References | PDF (754.4 KB)
  • 716 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Journal Club

Article
Tissue preservation with mass spectroscopic analysis: Implications for cancer diagnostics
O. Morgan Hall, Cody J. Peer & William D. Figg
Pages: 953-955
Published online: 31 May 2018
AbstractforTissue preservation with mass spectroscopic analysis: Implications for cancer diagnostics | Full Text | References | PDF (362.1 KB)
  • 794 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Bedside to Bench Report

Report
Preliminary clinical application of an aromatase inhibitor and a gonadotropin-releasing hormone agonist combination for inoperable endometrial cancer patients with comorbidities: case report and literature review
Mengting Dong, Su Jiang, Wenyan Tian, Ye Yan, Chao Gao, Jinping Gao, Yan Sheng, Yingmei Wang & Fengxia Xue
Pages: 956-961
Published online: 03 May 2018
AbstractforPreliminary clinical application of an aromatase inhibitor and a gonadotropin-releasing hormone agonist combination for inoperable endometrial cancer patients with comorbidities: case report and literature review | Full Text | References | PDF (514.4 KB)
  • 922 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Report
CMTR1-ALK: an ALK fusion in a patient with no response to ALK inhibitor crizotinib
Xue Du, Yun Shao, Hongjun Gao, Xueli Zhang, Han Zhang, Yi Ban, Haifeng Qin & Yanhong Tai
Pages: 962-966
Published online: 01 Oct 2018
AbstractforCMTR1-ALK: an ALK fusion in a patient with no response to ALK inhibitor crizotinib | Full Text | References | PDF (1 MB) | Supplemental
  • 1614 Views
  • 18 CrossRef citations
  • 0Altmetric
Open Access
Report
Double amplifications of CDK4 and MDM2 in a gastric inflammatory myofibroblastic tumor mimicking cancer with local invasion of the spleen and diaphragm
Jia He, Xinyi Zhao, Cheng Huang, Xiaoyun Zhou, Yan You, Lu Zhang, Chongmei Lu, Fang Yao & Shanqing Li
Pages: 967-972
Published online: 25 Sep 2018
AbstractforDouble amplifications of CDK4 and MDM2 in a gastric inflammatory myofibroblastic tumor mimicking cancer with local invasion of the spleen and diaphragm | Full Text | References | PDF (1.2 MB)
  • 959 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
MiR-135a-5p represses proliferation of HNSCC by targeting HOXA10
Lei-ming Guo, Gao-feng Ding, Wencai Xu, Hong Ge, Yue Jiang, Xi-juan Chen & Yufei Lu
Pages: 973-983
Published online: 06 Sep 2018
AbstractforMiR-135a-5p represses proliferation of HNSCC by targeting HOXA10 | Full Text | References | PDF (1.4 MB) | Supplemental
  • 1150 Views
  • 33 CrossRef citations
  • 0Altmetric
Free Access
Article
Hypoxia-mediated miR-212-3p downregulation enhances progression of intrahepatic cholangiocarcinoma through upregulation of Rab1a
Panzhang Hou, Yi Kang & Jianchao Luo
Pages: 984-993
Published online: 14 May 2018
AbstractforHypoxia-mediated miR-212-3p downregulation enhances progression of intrahepatic cholangiocarcinoma through upregulation of Rab1a | Full Text | References | PDF (1.3 MB)
  • 741 Views
  • 15 CrossRef citations
  • 0Altmetric
Free Access
Article
Association between genetic variants in p53 binding sites and risks of osteosarcoma in a Chinese population: a two-stage case-control study
Jingzhe Zhang, Li kai, Wenlong Zhang, Yu Yin & Wenjun Wang
Pages: 994-997
Published online: 18 Jun 2018
AbstractforAssociation between genetic variants in p53 binding sites and risks of osteosarcoma in a Chinese population: a two-stage case-control study | Full Text | References | PDF (302.4 KB)
  • 500 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
LncRNA DUXAP10 modulates cell proliferation in esophageal squamous cell carcinoma through epigenetically silencing p21
Zhongqiu Wang, Binhui Ren, Jianfeng Huang, Rong Yin, Feng Jiang & Qin Zhang
Pages: 998-1005
Published online: 14 Sep 2018
AbstractforLncRNA DUXAP10 modulates cell proliferation in esophageal squamous cell carcinoma through epigenetically silencing p21 | Full Text | References | PDF (1 MB)
  • 784 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access
Article
The prognostic correlation between CD105 expression level in tumor tissue and peripheral blood and sunitinib administration in advanced hepatocellular carcinoma
Yi Yang, Qiaobin Guan, Li Guo & Chenyang Han
Pages: 1006-1014
Published online: 05 Sep 2018
AbstractforThe prognostic correlation between CD105 expression level in tumor tissue and peripheral blood and sunitinib administration in advanced hepatocellular carcinoma | Full Text | References | PDF (959.9 KB)
  • 602 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Article
Preclinical evaluation of novel PI3K/mTOR dual inhibitor SN202 as potential anti-renal cancer agent
Wan Wang, Lidong Liao, Yujun Wang, Hui Li, Zili Suo, Kai Long & Peixiao Tang
Pages: 1015-1022
Published online: 27 Sep 2018
AbstractforPreclinical evaluation of novel PI3K/mTOR dual inhibitor SN202 as potential anti-renal cancer agent | Full Text | References | PDF (904.5 KB) | Supplemental
  • 775 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Article
Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma
Jiale Wang, Tamara Mirzapoiazova, Yi-Hung Carol Tan, Ka Ming Pang, Alex Pozhitkov, Yingyu Wang, Yang Wang, Bolot Mambetsariev, Edward Wang, Mohd W. Nasser, Surinder K. Batra, Dan Raz, Karen Reckamp, Prakash Kulkarni, Yanfang Zheng & Ravi Salgia
Pages: 1023-1032
Published online: 12 Oct 2018
AbstractforInhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma | Full Text | References | PDF (1.8 MB) | Supplemental
  • 1645 Views
  • 10 CrossRef citations
  • 0Altmetric
Open Access
Article
The transcription-independent mitochondrial cell death pathway is defective in non-transformed cells containing the Pro47Ser variant of p53
Anna Budina-Kolomets, Thibaut Barnoud & Maureen E. Murphy
Pages: 1033-1038
Published online: 27 Sep 2018
AbstractforThe transcription-independent mitochondrial cell death pathway is defective in non-transformed cells containing the Pro47Ser variant of p53 | Full Text | References | PDF (1.2 MB) | Supplemental
  • 852 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Article
Long non-coding RNA MEG3 suppresses the development of bladder urothelial carcinoma by regulating miR-96 and TPM1
Guanghua Liu, Xin Zhao, Jingmin Zhou, Xiangming Cheng, Zixing Ye & Zhigang Ji
Pages: 1039-1056
Published online: 21 Nov 2018
AbstractforLong non-coding RNA MEG3 suppresses the development of bladder urothelial carcinoma by regulating miR-96 and TPM1 | Full Text | References | PDF (4.2 MB) | Supplemental
  • 982 Views
  • 32 CrossRef citations
  • 0Altmetric
Free Access
Article
Sorafenib inhibits caspase-1 expression through suppressing TLR4/stat3/SUMO1 pathway in hepatocellular carcinoma
Jun Li, Yuan Zhou, Yang Liu, Bo Dai, Yu-Hen Zhang, Peng-Fei Zhang & Xiao-Lei Shi
Pages: 1057-1064
Published online: 02 Oct 2018
AbstractforSorafenib inhibits caspase-1 expression through suppressing TLR4/stat3/SUMO1 pathway in hepatocellular carcinoma | Full Text | References | PDF (1.5 MB) | Supplemental
  • 1605 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access
Article
FOXD4 induces tumor progression in colorectal cancer by regulation of the SNAI3/CDH1 axis
Cheng Chen, Maimaiti Aihemaiti, Xin Zhang, Hui Qu, Jie Jiao, Qilong Sun & Wenbin Yu
Pages: 1065-1071
Published online: 25 Sep 2018
AbstractforFOXD4 induces tumor progression in colorectal cancer by regulation of the SNAI3/CDH1 axis | Full Text | References | PDF (1.4 MB) | Supplemental
  • 894 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Errata

Correction
Erratum
Page: 1072
Published online: 29 May 2018
CitationforErratum | Full Text | PDF (205.6 KB)
  • 426 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles